| MYF5 |
MYF5: Myogenic factor 5 |
RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
1.307 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
ITGA2B |
ITGA2B, GP2B, ITGAB: Integrin alpha-IIb precursor |
1.307 |
Evidence |
|
| FIGF |
FIGF, VEGFD: Vascular endothelial growth factor D precursor |
CD5 |
CD5, LEU1: T-cell surface glycoprotein CD5 precursor |
1.307 |
Evidence |
|
| PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
SLAMF1 |
SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor |
1.307 |
Evidence |
|
| CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
IFI35 |
IPI00218475 |
1.307 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
ABCF1 |
IPI00013495 |
1.307 |
Evidence |
|
| NRAS |
NRAS, HRAS1: GTPase NRas precursor |
KRT18 |
KRT18: Uncharacterized protein KRT18 |
1.307 |
Evidence |
|
| F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
1.307 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
1.307 |
Evidence |
|
| KRT18 |
KRT18: Uncharacterized protein KRT18 |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
1.307 |
Evidence |
|
| TOM1L1 |
TOM1L1, SRCASM: TOM1-like protein 1 |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
1.307 |
Evidence |
|
| PPID |
PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase |
TPBG |
TPBG, 5T4: Trophoblast glycoprotein precursor |
1.307 |
Evidence |
|
| APC |
IPI00215877 |
DSG3 |
DSG3: Desmoglein-3 precursor |
1.307 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
VCPIP1 |
VCPIP1, KIAA1850, VCIP135: Deubiquitinating protein VCIP135 |
1.307 |
Evidence |
|
| NRAS |
NRAS, HRAS1: GTPase NRas precursor |
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
1.307 |
Evidence |
|
| SERPINA4 |
SERPINA4, KST, PI4: Kallistatin precursor |
MPZL1 |
MPZL1, PZR, UNQ849/PRO1787: Myelin protein zero-like protein 1 precursor |
1.307 |
Evidence |
|
| F3 |
F3: Tissue factor precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
1.307 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
STIP1 |
STIP1: Stress-induced-phosphoprotein 1 |
1.307 |
Evidence |
|
| STAM2 |
STAM2: Signal transducing adapter molecule 2 |
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
1.307 |
Evidence |
|
| F2RL3 |
F2RL3, PAR4: Proteinase-activated receptor 4 precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
1.307 |
Evidence |
|
| APC |
IPI00215877 |
CDH5 |
CDH5: Cadherin-5 precursor |
1.307 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
MAPK7 |
mitogen-activated protein kinase 7 isoform 1 |
1.307 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
1.307 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
1.307 |
Evidence |
|
| KCNJ1 |
KCNJ1, ROMK1: ATP-sensitive inward rectifier potassium channel 1 |
HP |
HP: Haptoglobin precursor [Contains: Haptoglobin alpha chain; Haptoglobin beta c |
1.307 |
Evidence |
|